Status:
UNKNOWN
CHACO Study: Control of Arterial Hypertension in Colombian Patients
Lead Sponsor:
Scandinavia Pharma
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Epidemiological study (cross-sectional study) in order to determine the patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arteri...
Detailed Description
OBJECTIVE: To determine the proportion of patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who a...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Prior diagnosis of Arterial Hypertension (AH) ≥ 3 months before
- Patients who are under pharmacological treatment of AH ≥ 3 months before
Exclusion
- The patient has rejected the participation in the study.
- Patients who, in the judgment of the Investigator, do not understand or are not willing to adequately answer the questions.
- Mental or psychiatric illness that, in the judgment of the investigator, does not allow adequate information to be obtained.
Key Trial Info
Start Date :
June 27 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
1100 Patients enrolled
Trial Details
Trial ID
NCT04094714
Start Date
June 27 2019
End Date
July 1 2024
Last Update
September 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scandinavia Pharma
Bogotá, Colombia, 110111